搜尋





搜尋





Stoke Therapeutics Inc

STOK

添加自選

25.550USD

-0.560-2.15%

交易中 09/24, 11:12（美東）

1.59B總市值

虧損本益比TTM

Stoke Therapeutics Inc

25.550

-0.560-2.15%

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

STOK 利潤表

您可以在這裡找到Stoke Therapeutics Inc的年度或季度收入報告，以深入了解Stoke Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

營業總收入

-32.51%9.32M

-96.07%6.23M

-93.80%1.40M

117.25%10.63M

186.01%13.82M

3661.12%158.57M

707.07%22.61M

47.94%4.89M

294.72%4.83M

-18.17%4.22M

-14.26%2.80M

13.87%3.31M

-176.79%-2.48M

71.73%5.15M

--3.27M

--2.91M

--3.23M

--3.00M

--0.00

----

--0.00

營業收入

-32.51%9.32M

-96.07%6.23M

-93.80%1.40M

117.25%10.63M

186.01%13.82M

3661.12%158.57M

707.07%22.61M

47.94%4.89M

294.72%4.83M

-18.17%4.22M

-14.26%2.80M

13.87%3.31M

-176.79%-2.48M

71.73%5.15M

--3.27M

--2.91M

--3.23M

--3.00M

--0.00

----

--0.00

營業費用

81.81%74.75M

26.03%59.65M

73.27%62.84M

53.95%53.72M

20.32%41.12M

45.23%47.33M

11.98%36.27M

14.26%34.90M

11.02%34.17M

9.20%32.59M

6.39%32.39M

1.63%30.54M

8.12%30.78M

7.36%29.84M

24.13%30.44M

32.49%30.05M

29.23%28.47M

65.18%27.80M

68.15%24.53M

65.44%22.68M

69.30%22.03M

43.39%16.83M

31.79%14.59M

39.31%13.71M

54.08%13.01M

85.62%11.73M

143.68%11.07M

196.71%9.84M

180.56%8.45M

230.65%6.32M

--4.54M

--3.32M

--3.01M

--1.91M

研發費用

91.46%49.50M

21.41%39.67M

78.01%41.70M

69.76%37.70M

22.33%25.86M

46.08%32.68M

7.55%23.42M

9.54%22.20M

2.85%21.14M

13.94%22.37M

3.41%21.78M

0.81%20.27M

11.95%20.55M

7.22%19.63M

33.27%21.06M

40.05%20.11M

30.24%18.36M

84.70%18.31M

77.47%15.80M

77.06%14.36M

76.90%14.10M

37.39%9.91M

25.60%8.90M

24.41%8.11M

32.29%7.97M

74.57%7.21M

135.99%7.09M

192.68%6.52M

219.01%6.02M

230.11%4.13M

--3.00M

--2.23M

--1.89M

--1.25M

折舊攤銷及損耗

2.69%458.00K

-7.97%439.00K

-23.00%405.00K

-18.15%442.00K

-18.61%446.00K

-15.28%477.00K

-15.71%526.00K

-15.23%540.00K

-10.31%548.00K

-5.70%563.00K

2.46%624.00K

64.18%637.00K

102.32%611.00K

141.70%597.00K

159.15%609.00K

52.76%388.00K

21.29%302.00K

4.66%247.00K

-5.62%235.00K

8.55%254.00K

11.16%249.00K

22.28%236.00K

79.14%249.00K

85.71%234.00K

113.33%224.00K

141.25%193.00K

85.33%139.00K

96.88%126.00K

144.19%105.00K

150.00%80.00K

--75.00K

--64.00K

--43.00K

--32.00K

營業利潤

-139.67%-65.43M

-148.02%-53.42M

-350.00%-61.44M

-43.62%-43.09M

6.96%-27.30M

492.08%111.24M

53.85%-13.65M

-10.17%-30.00M

11.79%-29.34M

-14.91%-28.37M

-8.87%-29.59M

-0.32%-27.23M

-31.79%-33.26M

0.42%-24.69M

-10.80%-27.18M

-19.68%-27.15M

-14.57%-25.24M

-47.35%-24.80M

-68.15%-24.53M

-65.44%-22.68M

-69.30%-22.03M

-43.39%-16.83M

-31.79%-14.59M

-39.31%-13.71M

-54.08%-13.01M

-85.62%-11.73M

-143.68%-11.07M

-196.71%-9.84M

-180.56%-8.45M

-230.65%-6.32M

---4.54M

---3.32M

---3.01M

---1.91M

淨非營業利息收入（費用）

利息收入

-7.55%3.50M

17.58%3.40M

21.72%3.62M

-2.31%3.46M

2.54%3.79M

19.08%2.89M

14.80%2.97M

33.72%3.54M

43.94%3.69M

15.36%2.43M

74.92%2.59M

166.43%2.65M

371.88%2.57M

1922.12%2.10M

4008.33%1.48M

2161.36%995.00K

1500.00%544.00K

477.78%104.00K

260.00%36.00K

300.00%44.00K

-32.00%34.00K

-97.33%18.00K

-98.89%10.00K

-99.11%11.00K

-92.05%50.00K

16.21%674.00K

234.81%904.00K

--1.24M

--629.00K

--580.00K

--270.00K

--0.00

其他非經營性收入（費用）

1000.00%308.00K

-35.71%18.00K

-154.73%-110.00K

-89.29%3.00K

158.33%28.00K

106.54%28.00K

390.24%201.00K

-31.71%28.00K

-217.07%-48.00K

-1119.05%-428.00K

-2.38%41.00K

0.00%42.00K

50.00%42.00K

162.50%42.00K

180.00%42.00K

162.50%42.00K

833.33%28.00K

-27.27%16.00K

275.00%15.00K

700.00%16.00K

200.00%3.00K

--22.00K

140.00%4.00K

--2.00K

---3.00K

--0.00

---10.00K

--0.00

稅前利潤

-162.39%-61.62M

-143.80%-50.00M

-452.70%-57.93M

-49.92%-39.63M

8.61%-23.48M

532.84%114.16M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

所得稅

--0.00

-100.00%0.00

--0.00

---1.28M

--0.00

--1.28M

----

除稅後利潤

-162.39%-61.62M

-144.30%-50.00M

-452.70%-57.93M

-45.09%-38.35M

8.61%-23.48M

527.99%112.88M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

持續經營利潤

-162.39%-61.62M

-144.30%-50.00M

-452.70%-57.93M

-45.09%-38.35M

8.61%-23.48M

527.99%112.88M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

歸属于母公司的淨利潤

-162.39%-61.62M

-144.30%-50.00M

-452.70%-57.93M

-45.09%-38.35M

8.61%-23.48M

527.99%112.88M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

歸屬普通股東的淨利潤

-162.39%-61.62M

-144.30%-50.00M

-452.70%-57.93M

-45.09%-38.35M

8.61%-23.48M

527.99%112.88M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

基本每股收益

-131.93%-0.93

-140.64%-0.79

-432.58%-0.98

-39.47%-0.65

12.66%-0.40

442.07%1.95

69.36%-0.18

15.39%-0.47

33.58%-0.46

-7.60%-0.57

7.84%-0.60

16.30%-0.55

-10.47%-0.69

19.48%-0.53

1.99%-0.65

-7.75%-0.66

-4.93%-0.63

-43.63%-0.66

-59.93%-0.66

-49.47%-0.61

-52.64%-0.60

-36.57%-0.46

-23.63%-0.41

-56.34%-0.41

-51.77%-0.39

-76.90%-0.34

-137.28%-0.34

-140.06%-0.26

-159.76%-0.26

-200.28%-0.19

---0.14

---0.11

---0.10

---0.06

稀釋每股收益

-131.93%-0.93

-141.72%-0.79

-432.58%-0.98

-39.47%-0.65

12.66%-0.40

433.23%1.90

69.36%-0.18

15.39%-0.47

33.58%-0.46

-7.60%-0.57

7.84%-0.60

16.30%-0.55

-10.47%-0.69

19.48%-0.53

1.99%-0.65

-7.75%-0.66

-4.93%-0.63

-43.63%-0.66

-59.93%-0.66

-49.47%-0.61

-52.64%-0.60

-36.57%-0.46

-23.63%-0.41

-56.34%-0.41

-51.77%-0.39

-76.90%-0.34

-137.28%-0.34

-140.06%-0.26

-159.76%-0.26

-200.28%-0.19

---0.14

---0.11

---0.10

---0.06

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Stoke Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 STOK 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Stoke Therapeutics Inc 財年末的營收是多少？



Stoke Therapeutics Inc 2025 財年營收為 184.42M，高於上一財年的 36.55M。

Stoke Therapeutics Inc 最近一個季度的營收是多少？



Stoke Therapeutics Inc 最近一個季度的營收為 9.32M，同比增長 -32.51%。

Stoke Therapeutics Inc 全年的淨利潤是多少？



Stoke Therapeutics Inc 2025 財年淨利潤為 -6.88M。

Stoke Therapeutics Inc 上一季度的淨利潤是多少？



Stoke Therapeutics Inc 最近一個季度的淨利潤為 -61.62M。

Stoke Therapeutics Inc 年度營業利潤是多少？



Stoke Therapeutics Inc 2025 財年的營業利潤為 -20.59M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。